| 0 |
Bismuth [EPC] |
805 |
0.1694 |
| 1 |
Carboxypeptidase [EPC] |
28 |
0.0982 |
| 2 |
Antihypoglycemic Agent [EPC] |
290 |
0.0942 |
| 3 |
Vasoconstrictor [EPC] |
18 |
0.0861 |
| 4 |
Anti-coagulant [EPC] |
474 |
0.0804 |
| 5 |
Glycopeptide Antibacterial [EPC] |
3634 |
0.0715 |
| 6 |
Metal Chelator [EPC] |
2 |
0.0714 |
| 7 |
Glinide [EPC] |
468 |
0.0655 |
| 8 |
Non-narcotic Antitussive [EPC] |
778 |
0.0648 |
| 9 |
Nucleoside Analog Antifungal [EPC] |
53 |
0.0579 |
| 10 |
alpha-Hydroxy Acid [EPC] |
83 |
0.0578 |
| 11 |
Interleukin-6 Antagonist [EPC] |
20 |
0.0557 |
| 12 |
Vitamin D3 Analog [EPC] |
955 |
0.0546 |
| 13 |
Potassium Binder [EPC] |
59 |
0.0546 |
| 14 |
Thiazide-like Diuretic [EPC] |
1868 |
0.0541 |
| 15 |
Proton Pump Inhibitor [EPC] |
25896 |
0.0536 |
| 16 |
Cephalosporin Antibacterial [EPC] |
368 |
0.0533 |
| 17 |
Aldosterone Antagonist [EPC] |
6308 |
0.0527 |
| 18 |
Vasopressin Receptor Agonist [EPC] |
10 |
0.0524 |
| 19 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
579 |
0.0515 |
| 20 |
Alkaloid [EPC] |
1170 |
0.0507 |
| 21 |
Fluoroquinolone Antibacterial [EPC] |
5273 |
0.0500 |
| 22 |
Sulfonamide Antibacterial [EPC] |
155 |
0.0475 |
| 23 |
Loop Diuretic [EPC] |
17686 |
0.0475 |
| 24 |
Lincosamide Antibacterial [EPC] |
1186 |
0.0459 |
| 25 |
Antimetabolite Immunosuppressant [EPC] |
564 |
0.0458 |
| 26 |
Monobactam Antibacterial [EPC] |
99 |
0.0451 |
| 27 |
Xanthine Oxidase Inhibitor [EPC] |
6369 |
0.0438 |
| 28 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
71 |
0.0425 |
| 29 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
412 |
0.0423 |
| 30 |
Tetracycline-class Drug [EPC] |
2157 |
0.0422 |
| 31 |
Lipopeptide Antibacterial [EPC] |
494 |
0.0411 |
| 32 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
684 |
0.0403 |
| 33 |
CD123 Interaction [EPC] |
13 |
0.0393 |
| 34 |
Echinocandin Antifungal [EPC] |
224 |
0.0383 |
| 35 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
4754 |
0.0382 |
| 36 |
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] |
2 |
0.0377 |
| 37 |
Central alpha-2 Adrenergic Agonist [EPC] |
1821 |
0.0374 |
| 38 |
Polyene Antifungal [EPC] |
1353 |
0.0371 |
| 39 |
alpha-Glucosidase Inhibitor [EPC] |
145 |
0.0367 |
| 40 |
Aluminum Complex [EPC] |
721 |
0.0366 |
| 41 |
Stimulant Laxative [EPC] |
410 |
0.0360 |
| 42 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
2784 |
0.0357 |
| 43 |
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC] |
30 |
0.0353 |
| 44 |
Nitrate Vasodilator [EPC] |
2668 |
0.0351 |
| 45 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
30 |
0.0349 |
| 46 |
alpha-Adrenergic Blocker [EPC] |
4163 |
0.0346 |
| 47 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
558 |
0.0345 |
| 48 |
Dihydropyridine Calcium Channel Blocker [EPC] |
9120 |
0.0343 |
| 49 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
36 |
0.0336 |
| 50 |
Humanized Monoclonal Antibody Fragment [EPC] |
44 |
0.0328 |
| 51 |
Selective T Cell Costimulation Blocker [EPC] |
112 |
0.0326 |
| 52 |
Serotonin-3 Receptor Antagonist [EPC] |
3140 |
0.0325 |
| 53 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
291 |
0.0325 |
| 54 |
P2Y12 Platelet Inhibitor [EPC] |
3085 |
0.0319 |
| 55 |
Lipid-based Polyene Antifungal [EPC] |
443 |
0.0314 |
| 56 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1489 |
0.0311 |
| 57 |
Cytochrome P450 3A Inhibitor [EPC] |
1761 |
0.0311 |
| 58 |
Macrolide Antimicrobial [EPC] |
1348 |
0.0311 |
| 59 |
Thiazide Diuretic [EPC] |
5883 |
0.0305 |
| 60 |
Blood Viscosity Reducer [EPC] |
104 |
0.0305 |
| 61 |
Quinolone Antimicrobial [EPC] |
245 |
0.0302 |
| 62 |
Nitrogen Binding Agent [EPC] |
3 |
0.0300 |
| 63 |
Penem Antibacterial [EPC] |
43 |
0.0295 |
| 64 |
Nitroimidazole Antimicrobial [EPC] |
1660 |
0.0294 |
| 65 |
Radiographic Contrast Agent [EPC] |
541 |
0.0292 |
| 66 |
Oxazolidinone Antibacterial [EPC] |
647 |
0.0291 |
| 67 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1980 |
0.0287 |
| 68 |
Folate Analog [EPC] |
19 |
0.0282 |
| 69 |
beta-Adrenergic Blocker [EPC] |
7567 |
0.0281 |
| 70 |
Chloride Channel Activator [EPC] |
225 |
0.0280 |
| 71 |
Lysosomal beta Glucuronidase [EPC] |
1 |
0.0278 |
| 72 |
Antidiarrheal [EPC] |
8 |
0.0277 |
| 73 |
Aminoglycoside Antibacterial [EPC] |
966 |
0.0276 |
| 74 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
24 |
0.0272 |
| 75 |
Azole Antifungal [EPC] |
3376 |
0.0271 |
| 76 |
Antimalarial [EPC] |
197 |
0.0266 |
| 77 |
Vitamin K [EPC] |
175 |
0.0263 |
| 78 |
Muscle Relaxant [EPC] |
1003 |
0.0260 |
| 79 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3047 |
0.0257 |
| 80 |
Potassium-sparing Diuretic [EPC] |
431 |
0.0257 |
| 81 |
CD22-directed Immunoconjugate [EPC] |
54 |
0.0255 |
| 82 |
Sulfonylurea [EPC] |
2883 |
0.0254 |
| 83 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
34 |
0.0254 |
| 84 |
Nitrofuran Antibacterial [EPC] |
530 |
0.0250 |
| 85 |
Tetracycline-class Antibacterial [EPC] |
130 |
0.0250 |
| 86 |
Lymphocyte Growth Factor [EPC] |
23 |
0.0247 |
| 87 |
Histamine-2 Receptor Antagonist [EPC] |
7081 |
0.0246 |
| 88 |
HMG-CoA Reductase Inhibitor [EPC] |
8977 |
0.0246 |
| 89 |
Protease Inhibitor [EPC] |
1049 |
0.0246 |
| 90 |
Phosphodiesterase 3 Inhibitor [EPC] |
131 |
0.0246 |
| 91 |
Rifamycin Antimycobacterial [EPC] |
64 |
0.0246 |
| 92 |
Tubulin Inhibiting Agent [EPC] |
6 |
0.0245 |
| 93 |
Bile Acid Sequestrant [EPC] |
229 |
0.0244 |
| 94 |
Pyrethroid [EPC] |
34 |
0.0240 |
| 95 |
Osmotic Diuretic [EPC] |
100 |
0.0237 |
| 96 |
l-Thyroxine [EPC] |
3495 |
0.0231 |
| 97 |
Cardiac Glycoside [EPC] |
1500 |
0.0229 |
| 98 |
Sulfone [EPC] |
188 |
0.0229 |
| 99 |
Benzodiazepine Antagonist [EPC] |
15 |
0.0227 |
| 100 |
Antiprotozoal [EPC] |
211 |
0.0225 |
| 101 |
Histamine-1 Receptor Antagonist [EPC] |
855 |
0.0220 |
| 102 |
Rifamycin Antibacterial [EPC] |
550 |
0.0220 |
| 103 |
Somatostatin Analog [EPC] |
105 |
0.0218 |
| 104 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
950 |
0.0217 |
| 105 |
Osmotic Laxative [EPC] |
3912 |
0.0215 |
| 106 |
Angiotensin 2 Receptor Blocker [EPC] |
6200 |
0.0214 |
| 107 |
CTLA-4-directed Blocking Antibody [EPC] |
735 |
0.0213 |
| 108 |
Opioid Agonist [EPC] |
5309 |
0.0212 |
| 109 |
General Anesthetic [EPC] |
727 |
0.0212 |
| 110 |
Platelet Aggregation Inhibitor [EPC] |
10999 |
0.0212 |
| 111 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
20863 |
0.0209 |
| 112 |
Vasopressin V2 Receptor Antagonist [EPC] |
195 |
0.0209 |
| 113 |
Partial Opioid Agonist/Antagonist [EPC] |
1 |
0.0208 |
| 114 |
Ileal Bile Acid Transporter Inhibitor [EPC] |
2 |
0.0208 |
| 115 |
Phenothiazine [EPC] |
480 |
0.0204 |
| 116 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
3226 |
0.0204 |
| 117 |
Serotonin Reuptake Inhibitor [EPC] |
1464 |
0.0203 |
| 118 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
322 |
0.0203 |
| 119 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1413 |
0.0202 |
| 120 |
Factor Xa Inhibitor [EPC] |
7825 |
0.0202 |
| 121 |
CD19-directed Chimeric Antigen Receptor [EPC] |
171 |
0.0198 |
| 122 |
Asparagine-specific Enzyme [EPC] |
210 |
0.0197 |
| 123 |
Hematopoietic Stem Cell Mobilizer [EPC] |
23 |
0.0196 |
| 124 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1771 |
0.0195 |
| 125 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1805 |
0.0194 |
| 126 |
Expectorant [EPC] |
3084 |
0.0193 |
| 127 |
Typical Antipsychotic [EPC] |
388 |
0.0189 |
| 128 |
CD30-directed Immunoconjugate [EPC] |
131 |
0.0188 |
| 129 |
l-Triiodothyronine [EPC] |
1 |
0.0185 |
| 130 |
Insulin Analog [EPC] |
7157 |
0.0183 |
| 131 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
83 |
0.0182 |
| 132 |
Cholinergic Muscarinic Antagonist [EPC] |
578 |
0.0178 |
| 133 |
Bile Acid [EPC] |
272 |
0.0175 |
| 134 |
Antifibrinolytic Agent [EPC] |
132 |
0.0175 |
| 135 |
Anticholinergic [EPC] |
224 |
0.0174 |
| 136 |
Platinum-based Drug [EPC] |
3441 |
0.0172 |
| 137 |
5-alpha Reductase Inhibitor [EPC] |
1055 |
0.0172 |
| 138 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
113 |
0.0170 |
| 139 |
Amide Local Anesthetic [EPC] |
1110 |
0.0169 |
| 140 |
Non-Standardized Fungal Allergenic Extract [EPC] |
57 |
0.0169 |
| 141 |
Hypoxia-inducible Factor Inhibitor [EPC] |
10 |
0.0167 |
| 142 |
Catecholamine [EPC] |
986 |
0.0167 |
| 143 |
Amino Acid Hypertonic Solution [EPC] |
1 |
0.0167 |
| 144 |
Anti-anginal [EPC] |
287 |
0.0165 |
| 145 |
Nonergot Dopamine Agonist [EPC] |
376 |
0.0161 |
| 146 |
Macrolide Antibacterial [EPC] |
29 |
0.0161 |
| 147 |
Cannabinoid [EPC] |
131 |
0.0160 |
| 148 |
Antiarrhythmic [EPC] |
1222 |
0.0158 |
| 149 |
Topoisomerase Inhibitor [EPC] |
923 |
0.0158 |
| 150 |
Antimycobacterial [EPC] |
249 |
0.0157 |
| 151 |
Proteasome Inhibitor [EPC] |
1440 |
0.0154 |
| 152 |
Plasma Volume Expander [EPC] |
8 |
0.0153 |
| 153 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
765 |
0.0152 |
| 154 |
CD38-directed Cytolytic Antibody [EPC] |
463 |
0.0151 |
| 155 |
Antileishmanial [EPC] |
4 |
0.0150 |
| 156 |
Corticosteroid [EPC] |
15113 |
0.0149 |
| 157 |
Lipid Emulsion [EPC] |
29 |
0.0147 |
| 158 |
Benzodiazepine [EPC] |
8869 |
0.0145 |
| 159 |
Provitamin D2 Compound [EPC] |
4389 |
0.0144 |
| 160 |
beta Lactamase Inhibitor [EPC] |
56 |
0.0143 |
| 161 |
Alkylating Drug [EPC] |
2767 |
0.0141 |
| 162 |
GLP-2 Analog [EPC] |
140 |
0.0141 |
| 163 |
Antidote [EPC] |
821 |
0.0138 |
| 164 |
Dopamine-2 Receptor Antagonist [EPC] |
79 |
0.0138 |
| 165 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
10 |
0.0138 |
| 166 |
Interferon gamma Blocker [EPC] |
1 |
0.0137 |
| 167 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
5 |
0.0133 |
| 168 |
Anthracycline Topoisomerase Inhibitor [EPC] |
14 |
0.0132 |
| 169 |
Histone Deacetylase Inhibitor [EPC] |
37 |
0.0130 |
| 170 |
Diagnostic Dye [EPC] |
2 |
0.0130 |
| 171 |
Barbiturate [EPC] |
135 |
0.0129 |
| 172 |
Vitamin B12 [EPC] |
3550 |
0.0129 |
| 173 |
Nucleoside Metabolic Inhibitor [EPC] |
3093 |
0.0128 |
| 174 |
Human Platelet-derived Growth Factor [EPC] |
27 |
0.0127 |
| 175 |
Vitamin D2 Analog [EPC] |
193 |
0.0126 |
| 176 |
CD33-directed Immunoconjugate [EPC] |
40 |
0.0123 |
| 177 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1120 |
0.0123 |
| 178 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
928 |
0.0122 |
| 179 |
Carbonic Anhydrase Inhibitor [EPC] |
200 |
0.0121 |
| 180 |
Parenteral Iron Replacement [EPC] |
129 |
0.0121 |
| 181 |
Vitamin C [EPC] |
3968 |
0.0120 |
| 182 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
609 |
0.0120 |
| 183 |
Vitamin D [EPC] |
3046 |
0.0118 |
| 184 |
Programmed Death Ligand-1 Blocker [EPC] |
134 |
0.0115 |
| 185 |
Nicotinic Acid [EPC] |
693 |
0.0114 |
| 186 |
Nuclear Export Inhibitor [EPC] |
64 |
0.0113 |
| 187 |
CD52-directed Cytolytic Antibody [EPC] |
195 |
0.0112 |
| 188 |
Small Interfering RNA [EPC] |
3 |
0.0112 |
| 189 |
Antiparasitic [EPC] |
53 |
0.0112 |
| 190 |
Pediculicide [EPC] |
54 |
0.0111 |
| 191 |
Non-Standardized Plant Allergenic Extract [EPC] |
109 |
0.0109 |
| 192 |
Interleukin-1 Receptor Antagonist [EPC] |
142 |
0.0109 |
| 193 |
Microtubule Inhibitor [EPC] |
1323 |
0.0108 |
| 194 |
Standardized Chemical Allergen [EPC] |
641 |
0.0103 |
| 195 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
51 |
0.0102 |
| 196 |
Anthelmintic [EPC] |
24 |
0.0101 |
| 197 |
Phosphodiesterase 5 Inhibitor [EPC] |
1093 |
0.0100 |
| 198 |
CCR5 Co-receptor Antagonist [EPC] |
21 |
0.0100 |
| 199 |
Guanylate Cyclase-C Agonist [EPC] |
207 |
0.0098 |
| 200 |
Leukotriene Receptor Antagonist [EPC] |
184 |
0.0097 |
| 201 |
Vitamin A [EPC] |
530 |
0.0096 |
| 202 |
Vitamin D Analog [EPC] |
162 |
0.0096 |
| 203 |
Erythropoiesis-stimulating Agent [EPC] |
636 |
0.0096 |
| 204 |
Purine Antimetabolite [EPC] |
724 |
0.0095 |
| 205 |
Aromatase Inhibitor [EPC] |
859 |
0.0095 |
| 206 |
Vitamin B6 Analog [EPC] |
472 |
0.0095 |
| 207 |
Erythroid Maturation Agent [EPC] |
10 |
0.0095 |
| 208 |
Insulin [EPC] |
453 |
0.0095 |
| 209 |
Sigma-1 Agonist [EPC] |
62 |
0.0094 |
| 210 |
Chemokine Receptor Type 4 Interaction [EPC] |
9 |
0.0094 |
| 211 |
Non-Standardized Food Allergenic Extract [EPC] |
163 |
0.0093 |
| 212 |
Soluble Guanylate Cyclase Stimulator [EPC] |
236 |
0.0092 |
| 213 |
Medium-chain Triglyceride [EPC] |
3 |
0.0091 |
| 214 |
Tricyclic Antidepressant [EPC] |
4 |
0.0091 |
| 215 |
Antiseptic [EPC] |
31 |
0.0091 |
| 216 |
Androgen [EPC] |
379 |
0.0091 |
| 217 |
GLP-1 Receptor Agonist [EPC] |
2068 |
0.0091 |
| 218 |
Cholinesterase Inhibitor [EPC] |
138 |
0.0090 |
| 219 |
Prostaglandin Analog [EPC] |
724 |
0.0090 |
| 220 |
Influenza A M2 Protein Inhibitor [EPC] |
107 |
0.0088 |
| 221 |
alpha-Adrenergic Agonist [EPC] |
446 |
0.0087 |
| 222 |
CD20-directed Cytolytic Antibody [EPC] |
1994 |
0.0086 |
| 223 |
Prostacyclin Receptor Agonist [EPC] |
173 |
0.0086 |
| 224 |
Melanin Synthesis Inhibitor [EPC] |
8 |
0.0086 |
| 225 |
Atypical Antipsychotic [EPC] |
3779 |
0.0085 |
| 226 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
5 |
0.0084 |
| 227 |
Methylxanthine [EPC] |
356 |
0.0083 |
| 228 |
Phosphate Binder [EPC] |
20 |
0.0081 |
| 229 |
Melatonin Receptor Agonist [EPC] |
94 |
0.0080 |
| 230 |
Nucleoside Analog Antiviral [EPC] |
640 |
0.0080 |
| 231 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
314 |
0.0079 |
| 232 |
Calcium [EPC] |
991 |
0.0079 |
| 233 |
CD4-directed Blocking Antibody [EPC] |
3 |
0.0079 |
| 234 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
299 |
0.0079 |
| 235 |
Ester Local Anesthetic [EPC] |
3 |
0.0078 |
| 236 |
Human Blood Coagulation Factor [EPC] |
2 |
0.0078 |
| 237 |
HER2/neu Receptor Antagonist [EPC] |
439 |
0.0076 |
| 238 |
Folate Analog Metabolic Inhibitor [EPC] |
2696 |
0.0076 |
| 239 |
Leptin Analog [EPC] |
7 |
0.0074 |
| 240 |
Kinase Inhibitor [EPC] |
3345 |
0.0074 |
| 241 |
BCL-2 Inhibitor [EPC] |
295 |
0.0072 |
| 242 |
Human Immunoglobulin G [EPC] |
68 |
0.0070 |
| 243 |
Cholecystokinin Analog [EPC] |
1 |
0.0069 |
| 244 |
Anti-epileptic Agent [EPC] |
1323 |
0.0067 |
| 245 |
Mood Stabilizer [EPC] |
1229 |
0.0067 |
| 246 |
Cholinergic Nicotinic Agonist [EPC] |
368 |
0.0067 |
| 247 |
CD19-directed Cytolytic Antibody [EPC] |
1 |
0.0066 |
| 248 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
984 |
0.0066 |
| 249 |
Adenosine Receptor Agonist [EPC] |
39 |
0.0062 |
| 250 |
beta3-Adrenergic Agonist [EPC] |
194 |
0.0062 |
| 251 |
Central Nervous System Stimulant [EPC] |
417 |
0.0062 |
| 252 |
Leukocyte Growth Factor [EPC] |
734 |
0.0061 |
| 253 |
Estrogen Receptor Antagonist [EPC] |
157 |
0.0060 |
| 254 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
271 |
0.0059 |
| 255 |
Arteriolar Vasodilator [EPC] |
219 |
0.0059 |
| 256 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
14 |
0.0059 |
| 257 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
7 |
0.0059 |
| 258 |
Prostacycline Vasodilator [EPC] |
623 |
0.0059 |
| 259 |
Radioactive Diagnostic Agent [EPC] |
9 |
0.0058 |
| 260 |
Prostaglandin E1 Analog [EPC] |
89 |
0.0058 |
| 261 |
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] |
1 |
0.0056 |
| 262 |
Pleuromutilin Antibacterial [EPC] |
4 |
0.0056 |
| 263 |
Androgen Receptor Inhibitor [EPC] |
362 |
0.0056 |
| 264 |
Thalidomide Analog [EPC] |
2330 |
0.0055 |
| 265 |
Actinomycin [EPC] |
13 |
0.0055 |
| 266 |
Adrenocorticotropic Hormone [EPC] |
5 |
0.0054 |
| 267 |
Parathyroid Hormone [EPC] |
24 |
0.0054 |
| 268 |
Uric Acid-specific Enzyme [EPC] |
11 |
0.0054 |
| 269 |
Iron Chelator [EPC] |
143 |
0.0053 |
| 270 |
Aminosalicylate [EPC] |
563 |
0.0053 |
| 271 |
Endothelin Receptor Antagonist [EPC] |
916 |
0.0053 |
| 272 |
Estrogen [EPC] |
854 |
0.0052 |
| 273 |
Interleukin-6 Receptor Antagonist [EPC] |
518 |
0.0052 |
| 274 |
Carnitine Analog [EPC] |
13 |
0.0052 |
| 275 |
Oxytocic [EPC] |
12 |
0.0049 |
| 276 |
Lipoglycopeptide Antibacterial [EPC] |
4 |
0.0048 |
| 277 |
Complement Inhibitor [EPC] |
236 |
0.0048 |
| 278 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
56 |
0.0047 |
| 279 |
Autologous Cellular Immunotherapy [EPC] |
23 |
0.0047 |
| 280 |
Endoglycosidase [EPC] |
14 |
0.0047 |
| 281 |
mu-Opioid Receptor Agonist [EPC] |
12 |
0.0046 |
| 282 |
Antirheumatic Agent [EPC] |
403 |
0.0045 |
| 283 |
Progestin Antagonist [EPC] |
17 |
0.0045 |
| 284 |
Orexin Receptor Antagonist [EPC] |
63 |
0.0045 |
| 285 |
Contrast Agent for Ultrasound Imaging [EPC] |
22 |
0.0044 |
| 286 |
Farnesoid X Receptor Agonist [EPC] |
26 |
0.0044 |
| 287 |
Aromatic Amino Acid [EPC] |
221 |
0.0042 |
| 288 |
Selectin Blocker [EPC] |
5 |
0.0042 |
| 289 |
Non-Standardized Chemical Allergen [EPC] |
95 |
0.0042 |
| 290 |
Opioid Antagonist [EPC] |
3 |
0.0042 |
| 291 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
191 |
0.0041 |
| 292 |
Janus Kinase Inhibitor [EPC] |
383 |
0.0041 |
| 293 |
Ergot Derivative [EPC] |
16 |
0.0041 |
| 294 |
Complement 5a Receptor Antagonist [EPC] |
7 |
0.0040 |
| 295 |
Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC] |
2 |
0.0040 |
| 296 |
Standardized Insect Venom Allergenic Extract [EPC] |
21 |
0.0040 |
| 297 |
Surfactant [EPC] |
4 |
0.0039 |
| 298 |
Neuraminidase Inhibitor [EPC] |
10 |
0.0039 |
| 299 |
Benzothiazole [EPC] |
8 |
0.0038 |
| 300 |
Polyene Antimicrobial [EPC] |
1 |
0.0038 |
| 301 |
Neonatal Fc Receptor Blocker [EPC] |
4 |
0.0038 |
| 302 |
Non-Standardized Insect Allergenic Extract [EPC] |
15 |
0.0037 |
| 303 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
56 |
0.0037 |
| 304 |
Prostacycline [EPC] |
35 |
0.0036 |
| 305 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
18 |
0.0035 |
| 306 |
Sympathomimetic-like Agent [EPC] |
101 |
0.0035 |
| 307 |
Calcitonin [EPC] |
10 |
0.0035 |
| 308 |
Partial Opioid Agonist [EPC] |
269 |
0.0033 |
| 309 |
Gadolinium-based Contrast Agent [EPC] |
13 |
0.0033 |
| 310 |
Photoactivated Radical Generator [EPC] |
2 |
0.0032 |
| 311 |
Progesterone [EPC] |
52 |
0.0031 |
| 312 |
Hedgehog Pathway Inhibitor [EPC] |
25 |
0.0031 |
| 313 |
RANK Ligand Inhibitor [EPC] |
545 |
0.0031 |
| 314 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
93 |
0.0031 |
| 315 |
Intestinal Lipase Inhibitor [EPC] |
76 |
0.0030 |
| 316 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
4 |
0.0030 |
| 317 |
Monoamine Oxidase Inhibitor [EPC] |
8 |
0.0030 |
| 318 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
50 |
0.0029 |
| 319 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
20 |
0.0029 |
| 320 |
Cytolytic Agent [EPC] |
6 |
0.0028 |
| 321 |
Sclerosing Agent [EPC] |
1 |
0.0027 |
| 322 |
Thrombopoietin Receptor Agonist [EPC] |
35 |
0.0027 |
| 323 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
4 |
0.0026 |
| 324 |
Reducing and Complexing Thiol [EPC] |
5 |
0.0026 |
| 325 |
Radioligand Therapeutic Agent [EPC] |
7 |
0.0024 |
| 326 |
Recombinant Human Growth Hormone [EPC] |
33 |
0.0023 |
| 327 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
33 |
0.0023 |
| 328 |
Cardiac Myosin Inhibitor [EPC] |
2 |
0.0020 |
| 329 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
1 |
0.0019 |
| 330 |
Selective T Cell Costimulation Modulator [EPC] |
203 |
0.0018 |
| 331 |
Skin Test Antigen [EPC] |
4 |
0.0018 |
| 332 |
Amyloid Beta-directed Antibody [EPC] |
1 |
0.0018 |
| 333 |
5-Lipoxygenase Inhibitor [EPC] |
1 |
0.0017 |
| 334 |
Interleukin-12 Antagonist [EPC] |
134 |
0.0017 |
| 335 |
Paramagnetic Contrast Agent [EPC] |
7 |
0.0016 |
| 336 |
Glucosylceramide Synthase Inhibitor [EPC] |
3 |
0.0015 |
| 337 |
Antisense Oligonucleotide [EPC] |
12 |
0.0015 |
| 338 |
Interleukin-23 Antagonist [EPC] |
181 |
0.0014 |
| 339 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
10 |
0.0013 |
| 340 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
8 |
0.0013 |
| 341 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
26 |
0.0013 |
| 342 |
Pyridone [EPC] |
45 |
0.0012 |
| 343 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
3 |
0.0012 |
| 344 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
1 |
0.0012 |
| 345 |
Integrin Receptor Antagonist [EPC] |
265 |
0.0012 |
| 346 |
Tumor Necrosis Factor Blocker [EPC] |
974 |
0.0011 |
| 347 |
Interleukin-17A Antagonist [EPC] |
163 |
0.0010 |
| 348 |
Hemoglobin S Polymerization Inhibitor [EPC] |
20 |
0.0010 |
| 349 |
Interferon alpha [EPC] |
56 |
0.0010 |
| 350 |
Interleukin-5 Antagonist [EPC] |
30 |
0.0010 |
| 351 |
Pyrimidine Synthesis Inhibitor [EPC] |
37 |
0.0009 |
| 352 |
Dopamine and Norepinephrine Reuptake Inhibitor [EPC] |
2 |
0.0009 |
| 353 |
Potassium Channel Blocker [EPC] |
58 |
0.0008 |
| 354 |
Interleukin-17 Receptor A Antagonist [EPC] |
1 |
0.0008 |
| 355 |
Estrogen Agonist/Antagonist [EPC] |
2 |
0.0008 |
| 356 |
Interferon gamma [EPC] |
1 |
0.0008 |
| 357 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
7 |
0.0007 |
| 358 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
1 |
0.0007 |
| 359 |
PCSK9 Inhibitor [EPC] |
91 |
0.0007 |
| 360 |
Gonadotropin [EPC] |
1 |
0.0007 |
| 361 |
Interferon beta [EPC] |
130 |
0.0007 |
| 362 |
Copper-containing Intrauterine Device [EPC] |
23 |
0.0006 |
| 363 |
Phosphodiesterase 4 Inhibitor [EPC] |
91 |
0.0006 |
| 364 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
6 |
0.0006 |
| 365 |
Parathyroid Hormone Analog [EPC] |
61 |
0.0006 |
| 366 |
Survival of Motor Neuron 2 Splicing Modifier [EPC] |
1 |
0.0005 |
| 367 |
Acetylcholine Release Inhibitor [EPC] |
40 |
0.0005 |
| 368 |
Anti-IgE [EPC] |
28 |
0.0005 |
| 369 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
7 |
0.0005 |
| 370 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
6 |
0.0005 |
| 371 |
Retinoid [EPC] |
100 |
0.0004 |
| 372 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
1 |
0.0004 |
| 373 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
2 |
0.0004 |
| 374 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
5 |
0.0004 |
| 375 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
2 |
0.0003 |
| 376 |
Progestin [EPC] |
78 |
0.0003 |
| 377 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
35 |
0.0002 |
| 378 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
1 |
0.0002 |
| 379 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
2 |
0.0001 |